These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 32049707)
1. Impact of Cooling on Lowering the Pain Threshold in Patients Undergoing Sclerotherapy. Coelho Neto F; Souza BR; Belczak SQ; de Araujo WJB; Gomes de Oliveira R Dermatol Surg; 2020 Nov; 46(11):e108-e111. PubMed ID: 32049707 [TBL] [Abstract][Full Text] [Related]
2. A double-blind, randomized study comparing pure chromated glycerin with chromated glycerin with 1% lidocaine and epinephrine for sclerotherapy of telangiectasias and reticular veins. Kern P; Ramelet AA; Wutschert R; Mazzolai L Dermatol Surg; 2011 Nov; 37(11):1590-4. PubMed ID: 21883648 [TBL] [Abstract][Full Text] [Related]
3. Comparison of sclerotherapy, laser, and radiowave coagulation in treatment of lower extremity telangiectasias. Tepavcevic B; Matic P; Radak D J Cosmet Laser Ther; 2012 Oct; 14(5):239-42. PubMed ID: 23016533 [TBL] [Abstract][Full Text] [Related]
4. Polidocanol versus hypertonic glucose for sclerotherapy treatment of reticular veins of the lower limbs: study protocol for a randomized controlled trial. Bertanha M; Sobreira ML; Pinheiro Lúcio Filho CE; de Oliveira Mariúba JV; Farres Pimenta RE; Jaldin RG; Moroz A; Moura R; Rollo HA; Yoshida WB Trials; 2014 Dec; 15():497. PubMed ID: 25527165 [TBL] [Abstract][Full Text] [Related]
5. Telangiectasias resistant to sclerotherapy are commonly connected to a perforating vessel. Schuller-Petrović S; Pavlović MD; Schuller S; Schuller-Lukic B; Adamic M Phlebology; 2013 Sep; 28(6):320-3. PubMed ID: 22865418 [TBL] [Abstract][Full Text] [Related]
6. Administration of Micronized Purified Flavonoid Fraction During Sclerotherapy of Reticular Veins and Telangiectasias: Results of the National, Multicenter, Observational Program VEIN ACT PROLONGED-C1. Bogachev VY; Boldin BV; Turkin PY Adv Ther; 2018 Jul; 35(7):1001-1008. PubMed ID: 29949043 [TBL] [Abstract][Full Text] [Related]
7. Treatment of Symptomatic Fluoroscopy-Associated Telangiectasias on the Dorsal Hand With Foam Sclerotherapy. Qureshi Z; Syed ZU Dermatol Surg; 2024 Aug; 50(8):779-781. PubMed ID: 38501664 [No Abstract] [Full Text] [Related]
8. Polidocanol Plus Glucose Versus Glucose Alone for the Treatment of Telangiectasias: Triple Blind, Randomised Controlled Trial (PG3T). Bertanha M; Yoshida WB; Bueno de Camargo PA; Moura R; Reis de Paula D; Padovani CR; Sobreira ML Eur J Vasc Endovasc Surg; 2021 Jan; 61(1):128-135. PubMed ID: 32778489 [TBL] [Abstract][Full Text] [Related]
9. Resolution of pain associated with varicose and telangiectatic leg veins after compression sclerotherapy. Weiss RA; Weiss MA J Dermatol Surg Oncol; 1990 Apr; 16(4):333-6. PubMed ID: 2324369 [TBL] [Abstract][Full Text] [Related]
10. Compression after sclerotherapy for telangiectasias and reticular leg veins: a randomized controlled study. Kern P; Ramelet AA; Wütschert R; Hayoz D J Vasc Surg; 2007 Jun; 45(6):1212-6. PubMed ID: 17467226 [TBL] [Abstract][Full Text] [Related]
11. Combination therapy of hyaluronic acid mesotherapic injections and sclerotherapy for treatment of lower leg telangiectasia without major venous insufficiency: a preliminary clinical study. Iannitti T; Rottigni V; Torricelli F; Palmieri B Clin Appl Thromb Hemost; 2014 Apr; 20(3):326-30. PubMed ID: 23076772 [TBL] [Abstract][Full Text] [Related]
12. Polidocanol versus glucose in the treatment of telangiectasia of the lower limbs (PG3T): Protocol for a randomized, controlled clinical trial. Bertanha M; Camargo PA; Moura R; Yoshida WB; Pimenta RE; Mariúba JV; Alcantara GP; de Paula DR; Sobreira ML Medicine (Baltimore); 2016 Sep; 95(39):e4812. PubMed ID: 27684809 [TBL] [Abstract][Full Text] [Related]
13. Sclerotherapy in tumescent anesthesia of reticular veins and telangiectasias. Ramelet AA Dermatol Surg; 2012 May; 38(5):748-51. PubMed ID: 22268802 [TBL] [Abstract][Full Text] [Related]
14. Migraine ophthalmique with reversible scotomas after sclerotherapy with liquid 1% polidocanol. Künzlberger B; Pieck C; Altmeyer P; Stücker M Dermatol Surg; 2006 Nov; 32(11):1410-3. PubMed ID: 17083597 [No Abstract] [Full Text] [Related]
16. Sclerotherapy of telangiectasias or spider veins in the lower limb: A review. Thomson L J Vasc Nurs; 2016 Jun; 34(2):61-2. PubMed ID: 27210454 [No Abstract] [Full Text] [Related]
17. Comparative pilot study evaluating the treatment of leg veins with a long pulse ND:YAG laser and sclerotherapy. Coles CM; Werner RS; Zelickson BD Lasers Surg Med; 2002; 30(2):154-9. PubMed ID: 11870796 [TBL] [Abstract][Full Text] [Related]
18. [Local drugs in treating and decreasing the incidence of adverse reactions after sclerotherapy of telangiectasia]. Bogachev VI; Boldin BV; Turkin PI; Lobanov VN Angiol Sosud Khir; 2019; 25(4):102-107. PubMed ID: 31855206 [TBL] [Abstract][Full Text] [Related]
19. Comparison and sequential study of long pulsed Nd:YAG 1,064 nm laser and sclerotherapy in leg telangiectasias treatment. Levy JL; Elbahr C; Jouve E; Mordon S Lasers Surg Med; 2004; 34(3):273-6. PubMed ID: 15022257 [TBL] [Abstract][Full Text] [Related]
20. Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study). Rabe E; Schliephake D; Otto J; Breu FX; Pannier F Phlebology; 2010 Jun; 25(3):124-31. PubMed ID: 20483861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]